Literature DB >> 32201338

Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy.

Marta Colaneri1, Elena Seminari1, Antonio Piralla2, Valentina Zuccaro1, Alessandro Di Filippo1, Fausto Baldanti3, Raffaele Bruno4, Mario U Mondelli5.   

Abstract

Entities:  

Year:  2020        PMID: 32201338      PMCID: PMC7156210          DOI: 10.1016/j.jhin.2020.03.018

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


× No keyword cloud information.
The World Health Organization defined Coronavirus Disease 2019 (COVID-19) as the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus belonging to the same subgenus as the severe acute respiratory syndrome Coronavirus (SARS-CoV). Human coronaviruses (HCoVs) spread in a similar fashion as Rhinoviruses, by direct contact with infected secretions or large aerosol droplets [1]. Healthcare workers are at increased risk of acquiring COVID-19 infection, possibly due to direct contact with the patients. Indeed, transmission of HCoVs through environmental contamination has been reported in healthcare settings [2]. Understanding which are the potentially contaminated surfaces in a healthcare environment is crucial to protect healthcare workers from this virus which is showing an unprecedented exponential trend with a doubling time of 3.6–4.1 days [3]. In this regard, studies suggest that surfaces and suspensions can carry HCoVs, increasing the risk of contact transmission that could lead to hospital-acquired HCoVs infections [4,5]. Otter et al. found that other coronaviruses (SARS-CoV, MERS-CoV) can be found on plastic, metal and cloths for up to 6 days [6]. Thus, monitoring environmental contamination of SARS-CoV-2 can support investigation of the current outbreak and benefit the management of COVID-19 infection. In addition, it may help in assessing the effectiveness of disinfection procedures and safety of personal protective equipment (PPE). Since 21 February 2020, when the first autochthonous case in Italy was confirmed, an overwhelming number of SARS-CoV-2 infections are continuously being detected, exceeding 8000 cases at the time of writing. Fondazione IRCCS Policlinico San Matteo, Pavia, is a 1300-bed tertiary teaching hospital in Northern Italy and a national SARS-CoV-2 referral center. The hospital houses 23 ICU beds and 44 Infectious Diseases (ID) beds, the latter being distributed over two floors. In the ID ward, each room has a buffer zone to allow safe donning and disposal of PPE. Healthcare workers involved in the direct care of patients use the following PPE: liquid-repelling gowns, double gloves, a class 2 filtering face-piece respirator (FFP2) and eye protection (goggles or face shield). Cleaning procedures have been standardized [7], in particular ward surfaces are cleaned with sodium hypochlorite at the concentration of 1000 ppm of free chlorine (0.1%) daily and 5000 ppm of free chlorine (0.5%) in terminal sanitization. From 21 to 29 February, 580 cases of SARS-CoV-2 were identified by the Virology laboratory, and those with interstitial pneumonia were admitted. Samples were collected on 28 February; by that day 100% of admitted patients were COVID-19 positive with pneumonia, and were treated with C-PAP or high flux oxygen. Surfaces in areas considered virus free were swabbed to search for COVID-19 RNA. Table I indicates which surfaces and objects were subjected to swabbing and Figure 1 illustrates the map of the ward where the test was carried out. Environmental samples were obtained using a sterile flexible nasopharyngeal nylon flocked premoistened swabs (FLOQSwabs™, Copan Italia, Brescia, Italy) dipped in 3 mL universal transport medium (UTM™, Copan Italia, Brescia, Italy). Total nucleic acids (DNA/RNA) were extracted from 200 μL of UTM™ using the QIAsymphony® instrument with QIAsymphony® DSP Virus/Pathogen Midi Kit (Complex 400 protocol) according to the manufacturer's instructions (QIAGEN, Qiagen, Hilden, Germany). Specific real-time reverse transcriptase–polymerase chain reaction (RT-PCR) targeting RNA-dependent RNA polymerase and E genes were used to detect the presence of SARS-CoV-2 according to WHO guidelines [8] and Corman et al. protocols [9].
Table I

List of objects and surfaces swabbed for SARS-CoV-2 RNA

High risk of contamination areaInanimate surfaces
Buffer zone of patients' roomsDoor handles
Waste container covers
Sink handles
Wall surfaces
Doctors' and nurses' loungeKitchen table and sink
Desks
Computer keyboards
Medical charts and parameters Tabs
Door handles
Therapy trolleys
Staff personal belongingsMobile phones
Figure 1

Map of the ward where swabs for SARS-CoV-2 RNA were obtained. Red dots indicate the sites where swabs were applied.

List of objects and surfaces swabbed for SARS-CoV-2 RNA Map of the ward where swabs for SARS-CoV-2 RNA were obtained. Red dots indicate the sites where swabs were applied. Sixteen swabs were collected from inanimate surfaces at high risk of contamination inside the wards. All inanimate surfaces and materials at high risk of contamination were free of SARS-CoV-2 RNA. At the time of writing no cases of COVID-19 have been detected in the staff involved in patient care. While this of course does not exclude the risk of transmission, it does provide evidence that the protective measures implemented in our setting significantly decrease the risk of environmental contamination and reduce concerns over healthcare workers' contamination and infection, at least from inanimate surfaces in areas that are either preserved as clean or decontaminated. Our findings therefore validate our cleaning and disinfection policies and confirm an adequate use of PPE. These data are in keeping with very recent findings reporting that anterooms, corridors and post-cleaning samples were negative for SARS-CoV-2 RNA, suggesting that current protections and decontamination procedures are sufficient despite extensive contamination of inanimate surfaces in patients' rooms and toilet sites [8]. In any case, environmental contamination with SARS-CoV-2 through respiratory droplets and faecal shedding suggests that the environment is indeed a potential medium of transmission [10]. Our study has limitations because virus viability was not investigated and the sample size was small, due to difficulty to run more tests during a time of emergency. A more precise evaluation of the infectious potential of the environment could be undertaken by collecting droplets from patients' sputum on inanimate surfaces and measuring SARS-CoV-2 infectious potential in vitro as a function of time. However, the emergency of the outbreak required a fast assessment of the current situation. While the pandemic still shows no sign of ending, further studies are underway to more comprehensively determine the potential of the environment as a transmission medium.
  8 in total

1.  Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source ofhospital-acquired infections.

Authors:  J Sizun; M W Yu; P J Talbot
Journal:  J Hosp Infect       Date:  2000-09       Impact factor: 3.926

2.  Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient.

Authors:  Sean Wei Xiang Ong; Yian Kim Tan; Po Ying Chia; Tau Hong Lee; Oon Tek Ng; Michelle Su Yen Wong; Kalisvar Marimuthu
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

3.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.

Authors:  Victor M Corman; Olfert Landt; Marco Kaiser; Richard Molenkamp; Adam Meijer; Daniel Kw Chu; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Marie Luisa Schmidt; Daphne Gjc Mulders; Bart L Haagmans; Bas van der Veer; Sharon van den Brink; Lisa Wijsman; Gabriel Goderski; Jean-Louis Romette; Joanna Ellis; Maria Zambon; Malik Peiris; Herman Goossens; Chantal Reusken; Marion Pg Koopmans; Christian Drosten
Journal:  Euro Surveill       Date:  2020-01

4.  Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials.

Authors:  Sarah L Warnes; Zoë R Little; C William Keevil
Journal:  MBio       Date:  2015-11-10       Impact factor: 7.867

5.  Early phylogenetic estimate of the effective reproduction number of SARS-CoV-2.

Authors:  Alessia Lai; Annalisa Bergna; Carla Acciarri; Massimo Galli; Gianguglielmo Zehender
Journal:  J Med Virol       Date:  2020-03-03       Impact factor: 2.327

6.  Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea.

Authors:  Seo Yu Bin; Jung Yeon Heo; Min-Suk Song; Jacob Lee; Eun-Ha Kim; Su-Jin Park; Hyeok-Il Kwon; Se Mi Kim; Young-Il Kim; Young-Jae Si; In-Won Lee; Yun Hee Baek; Won-Suk Choi; Jinsoo Min; Hye Won Jeong; Young Ki Choi
Journal:  Clin Infect Dis       Date:  2015-12-17       Impact factor: 9.079

Review 7.  Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination.

Authors:  J A Otter; C Donskey; S Yezli; S Douthwaite; S D Goldenberg; D J Weber
Journal:  J Hosp Infect       Date:  2015-10-03       Impact factor: 3.926

8.  Stability and inactivation of SARS coronavirus.

Authors:  H F Rabenau; J Cinatl; B Morgenstern; G Bauer; W Preiser; H W Doerr
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

  8 in total
  26 in total

1.  Low risk of SARS-CoV-2 transmission by fomites in real-life conditions.

Authors:  Mario U Mondelli; Marta Colaneri; Elena M Seminari; Fausto Baldanti; Raffaele Bruno
Journal:  Lancet Infect Dis       Date:  2020-09-29       Impact factor: 25.071

2.  The challenges of data usage for the United States' COVID-19 response.

Authors:  S E Galaitsi; Jeffrey C Cegan; Kaitlin Volk; Matthew Joyner; Benjamin D Trump; Igor Linkov
Journal:  Int J Inf Manage       Date:  2021-04-02

3.  Containing COVID-19 outside the isolation ward: The impact of an infection control bundle on environmental contamination and transmission in a cohorted general ward.

Authors:  Liang En Ian Wee; Xiang Ying Jean Sim; Edwin Philip Conceicao; May Kyawt Aung; Kwee Yuen Tan; Kwan Ki Karrie Ko; Hei Man Wong; Limin Wijaya; Ban Hock Tan; Indumathi Venkatachalam; Moi Lin Ling
Journal:  Am J Infect Control       Date:  2020-06-26       Impact factor: 2.918

4.  Aerosol and environmental surface monitoring for SARS-CoV-2 RNA in a designated hospital for severe COVID-19 patients.

Authors:  Y H Li; Y Z Fan; L Jiang; H B Wang
Journal:  Epidemiol Infect       Date:  2020-07-14       Impact factor: 2.451

5.  Estimation of effects of contact tracing and mask adoption on COVID-19 transmission in San Francisco: a modeling study.

Authors:  Lee Worden; Rae Wannier; Seth Blumberg; Alex Y Ge; George W Rutherford; Travis C Porco
Journal:  medRxiv       Date:  2020-06-11

6.  Sports balls as potential SARS-CoV-2 transmission vectors.

Authors:  Michel Pelisser; Joe Thompson; Dasha Majra; Sonia Youhanna; Justin Stebbing; Peter Davies
Journal:  Public Health Pract (Oxf)       Date:  2020-12-22

Review 7.  Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.

Authors:  Tobias Boettler; Philip N Newsome; Mario U Mondelli; Mojca Maticic; Elisa Cordero; Markus Cornberg; Thomas Berg
Journal:  JHEP Rep       Date:  2020-04-02

8.  Variation in microparasite free-living survival and indirect transmission can modulate the intensity of emerging outbreaks.

Authors:  C Brandon Ogbunugafor; Miles D Miller-Dickson; Victor A Meszaros; Lourdes M Gomez; Anarina L Murillo; Samuel V Scarpino
Journal:  Sci Rep       Date:  2020-11-27       Impact factor: 4.379

9.  Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity.

Authors:  Keiji Nakamura; Shinichiro Morioka; Satoshi Kutsuna; Shun Iida; Tadaki Suzuki; Noriko Kinoshita; Tetsuya Suzuki; Yuko Sugiki; Ayako Okuhama; Kohei Kanda; Yuji Wakimoto; Mugen Ujiie; Kei Yamamoto; Masahiro Ishikane; Yuki Moriyama; Masayuki Ota; Takato Nakamoto; Satoshi Ide; Hidetoshi Nomoto; Yutaro Akiyama; Yusuke Miyazato; Kayoko Hayakawa; Sho Saito; Norio Ohmagari
Journal:  Infect Prev Pract       Date:  2020-10-13

10.  SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.

Authors:  David A Coil; Timothy Albertson; Shefali Banerjee; Greg Brennan; A J Campbell; Stuart H Cohen; Satya Dandekar; Samuel L Díaz-Muñoz; Jonathan A Eisen; Tracey Goldstein; Ivy R Jose; Maya Juarez; Brandt A Robinson; Stefan Rothenburg; Christian Sandrock; Ana M M Stoian; Daniel G Tompkins; Alexandre Tremeau-Bravard; Angela Haczku
Journal:  PLoS One       Date:  2021-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.